Tata Motors reports 82% dip in sales in Q1

There are early recovery signs in a few sectors, and the company looks forward to a gradual pickup in demand on the back of overall economic recovery while continuing to address the challenges of intermittent demand and supply disruptions from COVID-19, Wagh added.

PTI

July 01, 2020 / 20:46 IST

Tata | Rs 65,000 | Tata Motors has partnered up with HDFC Bank to offer two new EMI schemes – A Gradual Step Up Scheme and a TML Flexi Drive scheme. Apart from this, the company also has a number of offers on its cars all the way up to Rs 65,000.

26 Aug, 2025 12:21

Volume

Todays L/H

Tata Motors on Wednesday reported 81.78 per cent dip in its total sales at 25,047 units in the first quarter ended June 30, 2020. The company had sold 1,37,545 units in the April-June quarter of 2019-20.

Domestic sales of the company stood at 23,845 units in the first quarter of the current fiscal, down 82 per cent from 1,31,879 units in same period of 2019-20, Tata Motors said in a statement.

“Amidst subdued demand environment, first quarter was marked by successful transition to BS-VI across the range of commercial vehicles," Tata Motors President, Commercial Vehicles Business Unit Girish Wagh said.

There are early recovery signs in a few sectors, and the company looks forward to a gradual pickup in demand on the back of overall economic recovery while continuing to address the challenges of intermittent demand and supply disruptions from COVID-19, he added.

The company's commercial vehicle sales during the quarter declined by 90 per cent to 10,476 units as compared with 1,00,357 units in same period of 2019-20.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show